United States: No X-Ray Vision At The FTC: Court Hands Agency A Rare Defeat In The Steris/Synergy Merger

In FTC v. Steris, the FTC was handed a rare litigation defeat. The case was notable because it involved a merger between companies who were not current competitors. The FTC alleged that without the merger, Synergy would have entered the US sterilization market with a disruptive new technology that would have undermined the current duopoly and benefited customers. The court found little in the evidence to support the FTC's theory. To be sure, there will be some soul-searching at the FTC as to how the Court could find the weight of the evidence so strongly on the side of the merging parties. However, because the case was decided on the single factual question of whether Synergy would have entered the U.S. market independently, the case has little precedential value and is unlikely to significantly alter the FTC's general approach to mergers involving potential competitors.

Introduction

In FTC v. Steris, District Court Judge Polster handed a rare defeat to the FTC. The case was notable because it involved a merger between companies who were not current competitors. The FTC alleged that without the merger, Synergy would have entered the US sterilization market with a disruptive new technology that would have undermined the current duopoly and benefited customers. The case was therefore about a merger that eliminated only future or actual potential competition. Although potential competition concerns are not novel for the FTC, this case was closely watched because it promised to be the first judicial treatment of potential competition in many years. Unfortunately for antitrust lawyers, the decision is something of a missed opportunity: the Court did not examine the validity or scope of the potential competition doctrine. Instead, the case was decided on the single question of whether the evidence showed that Synergy would have entered the US market within a reasonable period. On this key threshold question—which the Court rightly identified as the decisive issue—the Court found the evidence unequivocally supported the merging parties. The Court found that—given the enormous technical, financial, and business hurdles to entry and the notable lack of any customer commitments to an unproven technology—the FTC could not show that Synergy probably would have entered the market but for the merger.

Background

On October 13, 2014, the parties announced Ohio-based Steris' proposed acquisition of UK-based Synergy, for approximately $1.9 billion, which would combine the second and third largest medical sterilization companies in the world. Steris and Synergy claimed that the transaction would combine their geographically complementary businesses. Steris was one of only two US providers of contract gamma radiation sterilization services. Gamma radiation sterilization is the most effective and economical option for many healthcare products that are required to be sterilized by the FDA. Gamma radiation sterilization in the US is essentially a duopoly, with the top two providers accounting for about 85% of the market. By contrast, Synergy had only a small sterilization presence in the United States, with no US gamma offering. Although Synergy did not currently compete with Steris, the FTC focused on Synergy's plans to enter the United States with new x-ray based sterilization technology. After an intensive Second Request investigation, the FTC filed a complaint in the Northern District of Ohio seeking injunctive relief against the proposed transaction, alleging that Synergy would have become a significant competitor to Steris in contract sterilization services and that Synergy abandoned its entry plans because of the merger. The FTC also issued an Administrative Complaint challenging the merger.

Key Factors in the Decision

The court requested briefing and held three days of hearings in which it listened to testimony from Synergy executives as well as representatives from potential customers J&J and Zimmer. The Court found no support for the FTC's contention that Synergy abandoned its entry plans because of the merger. Instead, the Court decided that Synergy abandoned the project for legitimate business reasons unrelated to the merger. In the court's view, a lack of customer commitment, the inability to lower capital costs and other problems "plagued the development of x-ray sterilization" and justified Synergy's decision to terminate the entry project. While the FTC argued that Synergy's ordinary course documents established that the company was "poised" to enter the US with disruptive technology and an expectation of winning the incumbents' highest-valued customers, Synergy maintained that the documents painted a bleak outlook for the project, an assessment that the court accepted. Synergy's business models showed the entry strategy would fail every one of Synergy's internal financial metrics. In addition, while Synergy's Board had endorsed the idea, a formal business plan for US entry had never been presented to or approved by the Board. The court focused heavily on the risk profile of Synergy's entry strategy, noting that the investment was a "bet the farm" proposition that would consume Synergy's entire annual discretionary budget.

Critically, any investment decision would also need to be backed by long-term commitments from customers. However, despite intense marketing and sales efforts, Synergy was unable to obtain a single customer commitment to x-ray technology. Because of the high costs in obtaining FDA-validation for x-ray sterilization, the court observed that there was no financial incentive for customers to switch from existing technology to x-ray based services. The FTC asserted that it was the proposed merger and the FTC's own investigation into the deal that prompted Synergy to abandon its x-ray plans. Once again, the court disagreed, observing that Synergy did not terminate its plans until February 24, 2015, four months following the deal's announcement. Judge Polster noted that, "the timing of the decision to pull the plug on the US x-ray project may actually be the best evidence that it was done for legitimate business reasons, as opposed to anti-competitive ones. If the merger with Steris was going to prevent Synergy from entering the US market, Synergy would have stopped working on the US x-ray project as soon as the merger was announced in mid-October 2014."

 In the court's assessment, the x-ray entry strategy faced insurmountable hurdles that justified the decision to abandon the project entirely. Accordingly, the FTC could not carry its burden of establishing that Synergy would have entered the US market within a reasonable period but for the merger.

Conclusion

While the FTC may decide to appeal and/or may continue its in-house administrative proceedings against the merger, the prospects of a successful appeal are low. The decision was based on three days of oral hearings involving numerous determinations of witness credibility and a careful review of documentary evidence. To the extent it comes before the Court of Appeals, it will pay special deference to the District Court's account of the evidence and, if plausible, will not overturn the trial court even if it might have weighed the evidence differently.

Although there will be some soul-searching at the FTC as to how the Court could find the weight of the evidence so strongly on the side of the merging parties, the case is likely to have little impact on the FTC's general approach in potential competition cases. Indeed, if there is any solace for the FTC in this matter, it is that the Court was at least prepared to assume the validity of the actual potential competition doctrine rather than narrowly interpreting it in a way that may have constrained the Government's ability to challenge transactions on similar grounds in the future.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.